<SEC-DOCUMENT>0001193125-20-029893-index.html : 20200210 <SEC-HEADER>0001193125-20-029893.hdr.sgml : 20200210 <ACCEPTANCE-DATETIME>20200210164942 ACCESSION NUMBER: 0001193125-20-029893 CONFORMED SUBMISSION TYPE: S-3ASR PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20200210 DATE AS OF CHANGE: 20200210 EFFECTIVENESS DATE: 20200210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3ASR SEC ACT: 1933 Act SEC FILE NUMBER: 333-236351 FILM NUMBER: 20592596 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 </SEC-HEADER> <DOCUMENT> <TYPE>S-3ASR <SEQUENCE>1 <FILENAME>d829589ds3asr.htm <DESCRIPTION>S-3ASR <TEXT> Document 1 - file: d829589ds3asr.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>d829589dex51.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: d829589dex51.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>d829589dex231.htm <DESCRIPTION>EX-23.1 <TEXT> Document 3 - file: d829589dex231.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>4 <FILENAME>d829589dex232.htm <DESCRIPTION>EX-23.2 <TEXT> Document 4 - file: d829589dex232.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-25.1 <SEQUENCE>5 <FILENAME>d829589dex251.htm <DESCRIPTION>EX-25.1 <TEXT> Document 5 - file: d829589dex251.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>g829589g45a82.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: g829589g45a82.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>g829589g73t25.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 7 - file: g829589g73t25.jpg
</DOCUMENT> </SEC-DOCUMENT>